![Michael Wandell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Wandell worked as the Head of Regulatory & Clinical Affairs at Riot Platforms, Inc. and as the Senior Vice President of Regulatory Affairs at Epigenomics AG.
| Bedrijven | Functie | Einde |
|---|---|---|
| RIOT PLATFORMS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
| EPIGENOMICS AG | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 2 |
|---|---|
Riot Platforms, Inc.
 Riot Platforms, Inc. Information Technology ServicesTechnology Services Provides bitcoin mining services | Technology Services |
Epigenomics AG
 Epigenomics AG Medical SpecialtiesHealth Technology Engages in the development and commercialization of in vitro diagnostic tests for cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
